sham group will undergo a procedure that will closely mimic the active injection but with no penetration of the globe.
Sponsors
Laboratoires Thea
Conditions
Retinitis Pigmentosa
Phase 2
A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene
WithdrawnCTIS2024-515199-10-00
Target: 21Updated: 2025-03-24
A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene
Not yet recruitingCTIS2024-515199-10-01
Target: 31Updated: 2026-01-16